Jamwolf is correct, core business position has not changed, the...

Jamwolf is correct, core business position has not changed, the smoke and mirrors have. Watch the birdie !
Still reliant on AZ, engineering services and clinical.
Without a full understanding of the commercial sales in the US and patient acquisition data towards the 80,000 its really challenging to see a route to a sustainable profitable commercial company. If we are to get a return then that path needs to be clear and the CEO and Board need to address the lack of share liquidity.
If you look at what RESPIRI are doing on communicating to investors (ADR silent), pivoting to where the money is ( ADR - doggedly being a single technology product company) and being creative ( ADR retrograde strategy - nothing new, crank the handle while the monkey dances to the same tune for pennies). What are the CEO doing when they wake up ?